Eden Research (LON:EDEN) Trading Down 13.2% – Should You Sell?

Eden Research plc (LON:EDEN)’s share price was down 13.2% on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during mid-day trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Trading Up 3.5 %

The business has a 50-day simple moving average of GBX 3.36 and a 200-day simple moving average of GBX 3.71. The company has a market cap of £14.35 million, a PE ratio of -9.42 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling

In other Eden Research news, insider Alexander John Abrey purchased 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,952.94). Also, insider Sean M. Smith acquired 426,986 shares of Eden Research stock in a transaction dated Tuesday, April 1st. The stock was bought at an average price of GBX 234 ($3.03) per share, for a total transaction of £999,147.24 ($1,291,722.35). In the last 90 days, insiders have bought 1,391,473 shares of company stock valued at $103,604,725. Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.